What is the treatment for Postural Orthostatic Tachycardia Syndrome (POTS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For treating Postural Orthostatic Tachycardia Syndrome (POTS), I strongly recommend initiating a combination approach with non-pharmacological measures, including increased fluid intake, salt loading, and exercise, as these interventions address the underlying pathophysiology and have been shown to support long-term cardiovascular health 1.

Non-Pharmacological Interventions

These should be the first line of treatment for POTS. Key components include:

  • Increased fluid intake: Patients should drink 3 liters of water or an electrolyte-balanced fluid per day to help expand plasma volume.
  • Salt loading: Achieved through liberalized sodium intake (5-10 g or 1-2 teaspoons of table salt per day) to increase blood volume, provided blood pressure is controlled.
  • Elevation of the head of the bed: By 4–6-inch (10–15-cm) blocks during sleep to reduce symptoms of orthostatic intolerance.
  • Use of support stockings: Waist-high to ensure sufficient support of central blood volume and prevent pooling in the lower extremities.
  • Exercise program: A formalized exercise program should be initiated, which may include reclined aerobic exercise and strength training, starting with short sessions (5-10 minutes daily) and gradually increasing duration and intensity.

Pharmacological Interventions

If non-pharmacological measures are insufficient, medications can be considered:

  • Beta-blockers: Such as propranolol or metoprolol, may be used to slow the heart rate and improve exercise tolerance, especially if palpitations are a predominant symptom.
  • Midodrine: Can help increase blood pressure and alleviate orthostatic intolerance symptoms.
  • Fludrocortisone: May be used in conjunction with salt loading to increase blood volume.
  • Ivabradine: Specifically reduces heart rate without affecting blood pressure and may be useful in patients with severe fatigue exacerbated by other treatments.

Individualized Treatment Approach

Treatment of POTS should be highly individualized, focusing on the patient's specific symptoms and response to interventions. A combination of non-pharmacological and pharmacological approaches may be necessary for optimal symptom management. Regular monitoring and adjustments to the treatment plan are crucial to ensure the best possible outcomes in terms of morbidity, mortality, and quality of life 1.

From the Research

Treatment Approaches for Postural Orthostatic Tachycardia Syndrome (POTS)

The treatment for POTS involves a multifaceted approach, including lifestyle modifications and pharmacologic therapies. The primary goal of treatment is to increase the time patients can stand, perform daily activities, and exercise, while avoiding syncope 2.

Lifestyle Modifications

  • Increased fluid and salt intake to expand blood volume 3, 2, 4
  • Compression garment use to enhance venous return 3, 2, 4
  • Physical reconditioning and postural training to improve orthostatic tolerance 3, 2
  • Exercise training to improve cardiovascular function and reduce symptoms 2, 5, 4

Pharmacologic Therapies

  • Beta-blockers (e.g., propranolol, bisoprolol) to reduce heart rate and sympathetic activity in hyperadrenergic POTS 3, 2, 5, 4
  • Pyridostigmine to enhance vascular tone in neuropathic POTS 3, 2, 5
  • Midodrine to enhance vascular tone and reduce orthostatic intolerance 3, 2
  • Fludrocortisone to expand blood volume and reduce orthostatic intolerance 2
  • Other medications may be used to target specific symptoms, such as "brain fog," fatigue, sleep, and depression 6

Phenotype-Based Treatment

POTS patients can be categorized into three primary phenotypes: hyperadrenergic, neuropathic, and hypovolemic. Each phenotype requires tailored management strategies 3, 4.

  • Hyperadrenergic POTS: beta-blockers and avoidance of norepinephrine reuptake inhibitors 3, 4
  • Neuropathic POTS: agents that enhance vascular tone, such as pyridostigmine and midodrine 3, 2
  • Hypovolemic POTS: volume expansion and exercise 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical neurophysiology of postural tachycardia syndrome.

Handbook of clinical neurology, 2019

Research

Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2018

Research

Pharmacotherapy for postural tachycardia syndrome.

Autonomic neuroscience : basic & clinical, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.